NEOGENOMICS INC — Director's Dealing 2019

Feb 28, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2019-02-26

Reporting Person: HIPP RAYMOND R (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-02-26	Common Stock	M	10000	$4.78	Acquired	297580	Direct
2019-02-26	Common Stock	M	5556	$9.11	Acquired	303136	Direct
2019-02-26	Common Stock	M	3333	$7.27	Acquired	306469	Direct
2019-02-26	Common Stock	S	18889	$18.90	Disposed	287580	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-02-26	Stock Option (Right to Buy)	$4.78	M	10000	Disposed	2020-05-06	Common Stock (10000.0)	Direct
2019-02-26	Stock Option (Right to Buy)	$9.11	M	5556	Disposed	2021-07-28	Common Stock (5556.0)	Direct
2019-02-26	Stock Option (Right to Buy)	$7.27	M	3333	Disposed	2022-05-25	Common Stock (3333.0)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$11.6	2023-06-01	Common Stock (3017.0)	3017	Direct

Footnotes

F1: On May 6, 2015, Mr. Hipp was granted 10,000 stock options. The options vest ratably over the first three anniversary dates of the grant date.

F2: On July 28, 2016, Mr. Hipp was granted 8,333 stock options. The options vest ratably over the first three anniversary dates of the grant date.

F3: On May 25, 2017, Mr. Hipp was granted 10,000 stock options. The options vest ratably on the next three anniversary dates of the grant date.